Systemic inflammation has been elevated to a modifiable cardiovascular risk factor requiring assessment, monitoring, and modification, based on consensus recommendations.

A first-of-its-kind study in the Canadian Journal of Cardiology reveals the most impactful modifiable non-clinical risk factors for improved heart health Philadelphia, April 29, 2025 – A new study ...

Acute coronary syndrome (ACS) in younger patients presents distinctive epidemiological and clinical patterns when compared with older cohorts. Although traditionally viewed as a disease of older ...

A joint statement from the European Society of Cardiology, American College of Cardiology, World Heart Federation, and American Heart Association warns of major CV risk from environmental factors.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transglutaminase 2 (TGM2) has been implicated in various health conditions, yet its role in acute coronary ...

Advanced CKD in AMI patients receiving MCS is associated with increased mortality, complications, and resource utilization compared to those without advanced CKD. ESRD patients undergoing CABG after ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Discover how managing five key cardiovascular risk factors before age 50 can dramatically extend your healthy years—this global study reveals how small changes now can have life-changing effects later ...

An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...